MSSA
Anti-staphylococcal penicillins (i.e. cloxacillin) and cephalosporins (i.e. cefazolin) are optimal agents for intravenous therapy of MSSA infections.
Variable susceptibility to:
TMP-SMX,
Tetracyclines
Clindamycin
MRSA
Susceptible to:
Vancomycin
Daptomycin
Linezolid
Variably susceptible to:
TMP-SMX
Tetracyclines
Clindamycin
Rates of MSSA and MRSA resistance to clindamycin are high; clindamycin should NOT be used as empiric therapy for Staphylococcus aureus infections.